Off-market Deal: Upper Midwest Based Pharmaceutical Services Business ($2-3M EBITDA)

Project Ocean Beaver: Qualified users may request additional information via the PEmarket listing.

Project Ocean Beaver: Blinded Company Snapshot

• Transaction type: Acquisition of a Privately Held Operating Company
• Listing type: Off-market (Buy-side Mandate)
• Location: Upper Midwest
• Industry: Pharmaceuticals
• Revenue: $12-13 million
• EBITDA: $2-3 million 

Business Overview
The business supports pharmaceutical and specialty chemical companies throughout drug development and manufacturing by investigating material properties, identifying unknowns and impurities, developing analytical methods, and providing scientific interpretation for development, quality, regulatory, and manufacturing decisions. It also provides chemical intellectual property support.

Products & Services
The company provides solid-form development, including polymorph and salt screening, cocrystal development, crystallization, amorphous material development, and morphology engineering. Its analytical services cover structure elucidation, NMR, mass spectrometry, chromatography, X-ray diffraction, microscopy, thermal analysis, elemental analysis, particle characterization, and other advanced techniques. It also offers cGMP testing, analytical method development and validation, contaminant and impurity analysis, release testing, and intellectual property support.

Target Customer Base
The primary customers are pharmaceutical companies, specialty chemical companies, drug-development teams, R&D organizations, quality and regulatory teams, manufacturing groups, and legal/IP teams requiring specialized chemical analysis, materials characterization, development support, or expert scientific evidence.

Industry Market
The company operates in the pharmaceutical contract research, analytical testing, and specialty chemical laboratory services industry. Key demand drivers include pharmaceutical R&D, regulatory requirements, complex drug formulations, impurity and contamination investigations, analytical method development, solid-form optimization, and the need for specialized laboratory capabilities without maintaining all expertise and equipment in-house.

Market Geography
The business primarily serves pharmaceutical and chemical clients in the U.S. and international markets, supporting projects involving drug development, manufacturing, regulatory submissions, and intellectual property. Its website highlights experience with projects and IP matters worldwide.

Next Steps:

View the listing on PEmarket.com to request more information or Sign up for PEmarket to access additional lower middle market M&A opportunities.

Background Information & Disclaimers: PEmarket is a marketplace for lower middle market acquisition opportunities. We connect qualified acquirers, including strategic buyers, private equity firms, family offices, independent sponsors, and other acquisition professionals, directly with the buy-side and sell-side advisors representing listed opportunities. The information presented is a high-level summary provided solely for informational purposes. It does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product, and it is not intended as investment, legal, tax, or financial advice. This opportunity concerns a potential control-change acquisition of a privately held business. Additional information may be made available to qualified acquirers and other approved parties subject to the requirements of the seller, buyer, or their representative. Certain opportunities may require execution of confidentiality agreements, satisfaction of transaction-specific qualification criteria, and/or additional screening prior to the release of detailed information.